Isomonat Retard

Isosorbide mononitrate, the active ingredient in Isomonat Retard, is an organic nitrate presented as an oral formulation for oral use. It is employed to prevent angina pectoris and to manage chronic stable angina in adult patients. GNH USA supplies Isomonat Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isomonat Retard is used within the anti‑anginal/vasodilator class to relieve myocardial ischemia. - Prevention of angina pectoris: reduces the frequency of anginal attacks in patients with known coronary artery disease. - Chronic stable angina: improves exercise tolerance and decreases chest pain episodes during daily activities. - Ischemic heart disease management: lowers myocardial oxygen demand by vasodilation, helping to stabilize symptoms.

Adverse reactions may occur with any nitrate therapy.

Common Side Effects: - Headache: often transient and dose‑related. - Dizziness or light‑headedness. - Flushing of the skin. - Hypotension: mild to moderate blood pressure drop. - Nausea or gastrointestinal discomfort. - Palpitations or tachycardia.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Life‑threatening allergic reactions (anaphylaxis, angioedema). - Methemoglobinemia causing cyanosis. - Acute myocardial infarction in susceptible individuals. - Life‑threatening arrhythmias. - Persistent severe headache unresponsive to analgesics.

Before initiating therapy, clinicians should evaluate cardiovascular status and consider patient‑specific factors. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Cardiovascular assessment: ensure stable hemodynamics before use. - Avoid abrupt discontinuation: taper to prevent rebound angina. - Hepatic impairment: use with caution, adjust if necessary. - Renal impairment: monitor renal function and adjust dosing if required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Isomonat Retard can interact with several drug classes, altering its safety profile.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilation may cause severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of profound blood pressure fall.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, beta‑blockers, calcium channel blockers): may enhance blood‑pressure‑lowering effect. - Diuretics: can potentiate orthostatic hypotension. - Alcohol: may increase vasodilatory response and dizziness. - Azole antifungals (e.g., ketoconazole): possible increase in nitrate plasma levels.